PRPO
Precipio, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$21.89
+2.41%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 0.80x
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 3.21x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.66x
- Price / sales
- 1.43x
- Price / cash flow
- 35.62x
Enterprise value
- Enterprise value
- $39.4M
- EV / sales
- 1.44x
- EV / EBITDA
- 65.75x
- EV / EBIT
- -25.52x
- Market cap
- $39.2M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026